Display options
Cite
Brath U, Lau K, Van Petegem F, et al. Mapping the sevoflurane-binding sites of calmodulin. Pharmacol Res Perspect. 2014;2(1):5doi: 10.1002/prp2.25.
Brath, U., Lau, K., Van Petegem, F., & Erdélyi, M. (2014). Mapping the sevoflurane-binding sites of calmodulin. Pharmacology research & perspectives, 2(1), 5. https://doi.org/10.1002/prp2.25
Brath, Ulrika, et al. "Mapping the sevoflurane-binding sites of calmodulin." Pharmacology research & perspectives vol. 2,1 (2014): 5. doi: https://doi.org/10.1002/prp2.25
Brath U, Lau K, Van Petegem F, Erdélyi M. Mapping the sevoflurane-binding sites of calmodulin. Pharmacol Res Perspect. 2014 Feb;2(1):5. doi: 10.1002/prp2.25. Epub 2014 Feb 12. PMID: 25505574; PMCID: PMC4186402.
Copy Download .nbib Format: NLM
Share it on

Pharmacol Res Perspect. 2014 Feb;2(1):5. doi: 10.1002/prp2.25. Epub 2014 Feb 12.

Mapping the sevoflurane-binding sites of calmodulin.

Pharmacology research & perspectives

Ulrika Brath, Kelvin Lau, Filip Van Petegem, Máté Erdélyi

Affiliations

  1. Department of Chemistry and Molecular Biology and the Swedish NMR Centre, University of Gothenburg SE-412 96, Gothenburg, Sweden.
  2. Department of Biochemistry and Molecular Biology, University of British Columbia Vancouver, British Columbia, V6T 1Z3, Canada.

PMID: 25505574 PMCID: PMC4186402 DOI: 10.1002/prp2.25

Abstract

General anesthetics, with sevoflurane (SF) being the first choice inhalational anesthetic agent, provide reversible, broad depressor effects on the nervous system yet have a narrow margin of safety. As characterization of low-affinity binding interactions of volatile substances is exceptionally challenging with the existing methods, none of the numerous cellular targets proposed as chief protagonists in anesthesia could yet be confirmed. The recognition that most critical functions modulated by volatile anesthetics are under the control of intracellular Ca(2+) concentration, which in turn is primarily regulated by calmodulin (CaM), motivated us for characterization of the SF-CaM interaction. Solution NMR (Nuclear Magnetic Resonance) spectroscopy was used to identify SF-binding sites using chemical shift displacement, NOESY and heteronuclear Overhauser enhancement spectroscopy (HOESY) experiments. Binding affinities were measured using ITC (isothermal titration calorimetry). SF binds to both lobes of (Ca(2+))4-CaM with low mmol/L affinity whereas no interaction was observed in the absence of Ca(2+). SF does not affect the calcium binding of CaM. The structurally closely related SF and isoflurane are shown to bind to the same clefts. The SF-binding clefts overlap with the binding sites of physiologically relevant ion channels and bioactive small molecules, but the binding affinity suggests it could only interfere with very weak CaM targets.

Keywords: Anesthesia; ITC; NMR; anesthetic binding; calmodulin; sevoflurane

References

  1. J Mol Biol. 1988 Nov 5;204(1):191-204 - PubMed
  2. Environ Health Perspect. 1990 Jul;87:199-205 - PubMed
  3. Science. 1993 Dec 10;262(5140):1718-21 - PubMed
  4. FEBS Lett. 1991 Apr 9;281(1-2):33-8 - PubMed
  5. Microbes Infect. 1999 Sep;1(11):913-8 - PubMed
  6. Nature. 1978 Jul 27;274(5669):339-42 - PubMed
  7. Biochem Biophys Res Commun. 1980 Jul 16;95(1):1-6 - PubMed
  8. J Biol Chem. 2005 Mar 4;280(9):8266-74 - PubMed
  9. J Biomol NMR. 1995 Nov;6(3):277-93 - PubMed
  10. Br J Anaesth. 1993 Jul;71(1):47-58 - PubMed
  11. Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6478-82 - PubMed
  12. Anesthesiology. 1998 Jan;88(1):5-6 - PubMed
  13. Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3558-63 - PubMed
  14. Nat Struct Biol. 1994 Nov;1(11):795-801 - PubMed
  15. Mol Biotechnol. 2004 May;27(1):33-57 - PubMed
  16. Nature. 1994 Feb 17;367(6464):607-14 - PubMed
  17. Hum Mutat. 2006 Oct;27(10):977-89 - PubMed
  18. Annu Rev Physiol. 2002;64:289-311 - PubMed
  19. Biophys J. 2006 Nov 1;91(9):3405-14 - PubMed
  20. J Mol Graph. 1996 Feb;14(1):51-5, 29-32 - PubMed
  21. Biochem Biophys Res Commun. 1984 Jan 13;118(1):225-32 - PubMed
  22. Biochim Biophys Acta. 2004 May 3;1691(2-3):161-7 - PubMed
  23. Anesthesiology. 1995 Jul;83(1):120-6 - PubMed
  24. Eur J Biochem. 1995 Jun 15;230(3):1014-24 - PubMed
  25. Biochemistry. 1967 Jul;6(7):1948-54 - PubMed
  26. Biophys J. 2003 Nov;85(5):3279-85 - PubMed
  27. Trends Cell Biol. 2000 Aug;10(8):322-8 - PubMed
  28. Expert Opin Pharmacother. 2009 Apr;10(5):861-73 - PubMed
  29. Structure. 2006 Oct;14(10):1547-56 - PubMed
  30. FEBS Lett. 1995 Jun 12;366(2-3):104-8 - PubMed
  31. N Engl J Med. 1986 Apr 24;314(17):1094-101 - PubMed
  32. Mol Pharmacol. 2004 Oct;66(4):929-35 - PubMed
  33. Pharmacol Rev. 1997 Dec;49(4):343-67 - PubMed
  34. J Magn Reson. 2011 Dec;213(2):423-41 - PubMed
  35. J Biol Chem. 1980 Dec 10;255 (23 ):11078-80 - PubMed
  36. Sci Am. 2007 Jun;296(6):54-61 - PubMed
  37. Anesth Analg. 2007 Feb;104(2):318-24 - PubMed
  38. J Mol Biol. 1998 Feb 13;276(1):165-76 - PubMed
  39. Neuropsychopharmacology. 2003 Jul;28 Suppl 1:S40-7 - PubMed
  40. Nature. 2006 Mar 2;440(7080):52-7 - PubMed
  41. Nature. 1974 Dec 6;252(5483):471-2 - PubMed
  42. J Mol Model. 2007 Feb;13(2):313-8 - PubMed
  43. Ital J Neurol Sci. 1999 Dec;20(6):431-5 - PubMed
  44. J Phys Chem B. 2005 Sep 29;109(38):17795-8 - PubMed
  45. Anesth Analg. 1989 Jul;69(1):100-12 - PubMed
  46. Nature. 1984 Aug 16-22;310(5978):599-601 - PubMed
  47. AANA J. 2004 Jun;72(3):197-205 - PubMed
  48. Brain Res. 1991 Jan 11;538(2):319-23 - PubMed
  49. Acc Chem Res. 2005 May;38(5):386-95 - PubMed

Publication Types